RXST
Rxsight Inc
NASDAQ: RXST · HEALTHCARE · MEDICAL DEVICES
$6.81
-5.02% today
Updated 2026-04-29
Market cap
$295.88M
P/E ratio
—
P/S ratio
2.20x
EPS (TTM)
$-0.95
Dividend yield
—
52W range
$6 – $17
Volume
0.7M
Rxsight Inc (RXST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-40.62M | $-35.20M | $-44.71M | $-58.85M | $-41.59M | $-16.95M | $-15.51M |
| Capital expenditures | $4.09M | $2.54M | $1.94M | $2.39M | $4.81M | $5.44M | $3.83M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $4.60M | $4.18M | $7.58M | $11.40M | $15.75M | $24.64M | $31.61M |
| Free cash flow | $-44.70M | $-37.74M | $-46.65M | $-61.24M | $-46.41M | $-22.39M | $-19.34M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $643000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $10.73M | $-12.57M | — | — | — |